换一批摘要篇首： A large trial of the cholesterol lowering drug rosuvastatin showed that giving1 it to healthy adults reduced their risk of blood clots (venous thromboembolism) by 43 per cent. This was the result of a subgroup analysis in the JUPITER trial2, and was published online on 28 March in The Lancet and presented at the American College of Cardiology's 58th Annual Scientific Sessions.
更多相关知识
医学主题词
血栓形成(Thrombosis)
栏目名称
DOI
10.3969/j.issn.1008-1070.2009.10.032
发布时间
2009-12-08（万方平台首次上网日期，不代表论文的发表时间）
- 浏览59
- 被引0
- 下载4
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
